Pharma sector funds invest in pharmaceutical manufacturers, API makers, hospital chains, and healthcare companies. The sector is considered somewhat defensive — demand for medicines doesn't disappear in downturns. But it's also subject to regulatory risk from the US FDA and pricing pressure in export markets.
| Fund Name | AUM | 1Y Returns | TER(%) | |
|---|---|---|---|---|
| Category Average | ₹2,159 Cr | +14.81% | 1.23 | |
| Nippon India Pharma FundVery High | ₹9,166 Cr | +9.2% | 0.99 | View → |
| ICICI Prudential Healthcare FundVery High | ₹6,861 Cr | +5.1% | 1.31 | View → |
| SBI Healthcare Opportunities FundVery High | ₹5,870 Cr | +17.7% | 1.01 | View → |
| DSP Healthcare FundVery High | ₹3,750 Cr | +15.2% | 0.75 | View → |
| HDFC Pharma and Healthcare FundVery High | ₹3,501 Cr | +23.6% | 1.05 | View → |
| Mirae Asset Healthcare FundVery High | ₹3,494 Cr | +19.1% | 0.62 | View → |
| Tata India Pharma & Healthcare FundVery High | ₹1,511 Cr | +5.1% | 1.10 | View → |
| UTI Healthcare FundVery High | ₹1,430 Cr | +14.3% | 1.56 | View → |
| Aditya Birla Sun Life Pharma & Healthcare FundVery High | ₹1,078 Cr | +14.6% | 1.07 | View → |
| WhiteOak Capital Pharma and Healthcare FundVery High | ₹927 Cr | +19.1% | 1.06 | View → |
| Kotak Healthcare FundVery High | ₹838 Cr | +23.8% | 1.03 | View → |
| Baroda BNP Paribas Health and Wellness FundVery High | ₹487 Cr | +10.6% | 1.47 | View → |
| Invesco India Pharma And Healthcare FundVery High | ₹436 Cr | — | 3.30 | View → |
| Quant Healthcare FundVery High | ₹431 Cr | +17.0% | 1.56 | View → |
| Bajaj Finserv Healthcare FundVery High | ₹405 Cr | +18.6% | 0.90 | View → |
| Bandhan Healthcare FundVery High | ₹333 Cr | — | 1.25 | View → |
| ITI Pharma & Healthcare FundVery High | ₹266 Cr | +9.7% | 0.89 | View → |
| PGIM India Healthcare FundVery High | ₹130 Cr | +18.3% | 1.00 | View → |
| LIC MF Healthcare FundVery High | ₹99 Cr | +10.8% | 1.38 | View → |